TrialDiabetes & metabolism2018

Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes.

T S Bailey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.